Issued Patents All Time
Showing 26–42 of 42 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10836830 | Antibodies and methods of use thereof | Nicholas Stuart Wilson, Jeremy Dale Waight, Gerd Ritter, David Schaer, Daniel Hirschhorn-Cymerman +6 more | 2020-11-17 |
| 10829559 | Anti-GITR antibodies and methods of use thereof | Volker Seibert, Olivier Leger, Marc van Dijk, David Schaer, Gerd Ritter +1 more | 2020-11-10 |
| 10800849 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2020-10-13 |
| 10765711 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Jedd D. Wolchok, Weiyi Wang, Peihong Dai +1 more | 2020-09-08 |
| 10736962 | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Jedd D. Wolchok, Weiyi Wang, Peihong Dai +1 more | 2020-08-11 |
| 10639366 | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors | Liang Deng, Stewart Shuman, Jedd D. Wolchok, Peihong Dai, Weiyi Wang | 2020-05-05 |
| 10626181 | Nucleic acids encoding anti-OX40 antibodies | Marc van Dijk, Ekaterina V. Breous-Nystrom, Volker Seibert, Gerd Ritter, David Schaer +5 more | 2020-04-21 |
| 10577426 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2020-03-03 |
| 10548930 | Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors | Liang Deng, Jedd D. Wolchok, Stewart Shuman, Peihong Dai, Weiyi Wang | 2020-02-04 |
| 10512662 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Jedd D. Wolchok, Weiyi Wang, Peihong Dai +1 more | 2019-12-24 |
| 10479833 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Jedd D. Wolchok +2 more | 2019-11-19 |
| 10450373 | Anti-PD-1 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, Jedd D. Wolchok, Roberta Zappasodi +4 more | 2019-10-22 |
| 10323091 | Anti-PD-1 antibodies and methods of use thereof | Marc van Dijk, Nicholas Stuart Wilson, Cornelia Anne Mundt, Gerd Ritter, Jedd D. Wolchok +4 more | 2019-06-18 |
| 10280226 | Anti-GITR antibodies and methods of use thereof | Volker Seibert, Olivier Leger, Marc van Dijk, David Schaer, Gerd Ritter +1 more | 2019-05-07 |
| 10259882 | Anti-OX40 antibodies | Marc van Dijk, Ekaterina V. Breous-Nystrom, Gerd Ritter, David Schaer, Daniel Hirschhorn-Cymerman +3 more | 2019-04-16 |
| 10155818 | Anti-GITR antibodies and methods of use thereof | Volker Seibert, Olivier Leger, Marc van Dijk, David Schaer, Gerd Ritter +1 more | 2018-12-18 |
| 10144779 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Jedd D. Wolchok +2 more | 2018-12-04 |